HomeRCKTW • NASDAQ
add
Rocket Pharmaceuticals
Previous close
$0.039
Year range
$0.021 - $0.095
Market cap
403.56M USD
Avg Volume
34.68K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 67.68M | -8.19% |
Net income | -68.92M | 1.04% |
Net profit margin | — | — |
Earnings per share | -0.59 | 20.34% |
EBITDA | -65.10M | 8.75% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 271.49M | -2.63% |
Total assets | 420.98M | -5.70% |
Total liabilities | 66.77M | 8.08% |
Total equity | 354.21M | — |
Shares outstanding | 107.90M | — |
Price to book | 0.01 | — |
Return on assets | -37.93% | — |
Return on capital | -41.42% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -68.92M | 1.04% |
Cash from operations | -48.96M | 9.03% |
Cash from investing | 31.76M | -42.90% |
Cash from financing | 215.00K | -85.95% |
Net change in cash | -16.99M | -610.00% |
Free cash flow | -20.47M | 29.41% |
About
Founded
1999
Headquarters
Website
Employees
299
